EP
OPTN

Eversept Partners’s OptiNose OPTN Stock Holding History

Eversept Partners’s Portfolio OPTN Stock Details OPTN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-7,000
Closed -$968K – 74
2019
Q4 		$968K Sell
7,000
-7
-0.1% -$908 0.17% 65
2019
Q3 		$736K Hold
7,007
– – 0.23% 48
2019
Q2 		$744K Buy
+7,007
New +$923K 0.21% 49

Other funds holding OPTN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SW
SVB Wealth Boston, Massachusetts $1.59B AUM 24.57% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Eversept Partners's OPTN Position: Q1 2020 in Review

Eversept Partners sold out of OptiNose (OPTN) in Q1 2020, closing a stake of 7,000 shares — an estimated $968K sold.

Eversept Partners first reported a position in OPTN in Q2 2019 and held it in 3 quarters. The position peaked at $968K in Q4 2019. 81 funds tracked by Wall St. Rank hold OPTN as of Q1 2020.

  • Eversept Partners reported no remaining OptiNose position as of Q1 2020 after selling out during the quarter.
  • Eversept Partners sold 7,000 OptiNose shares in Q1 2020, an estimated $968K.
  • Eversept Partners first reported a position in OptiNose in Q2 2019 and held it in 3 quarters.
  • Eversept Partners's OptiNose position peaked at $968K in Q4 2019.
  • 81 funds tracked by Wall St. Rank held OptiNose as of Q1 2020.

Based on Eversept Partners's 13F filing for Q1 2020, filed 13 May 2020.